GlobeNewsWire
19 Dec 2025, 11:30 UTC · 39w ago
Verdict
Headline leans bullish. We score AMST +1.00 across four claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Amesite has seen massive quarterly revenue surges, including a 2.4x increase following the Teams+ launch and an 82% increase following the Enterprise tier launch.
More positive than 99% of claims this week
Amesite is launching the NurseMagic™ EMR, transitioning from a point-of-care AI tool to a core infrastructure electronic medical record system.
Continue reading
5 related stories
More positive than 98% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 93% of claims this week
The company has shifted its Enterprise pricing model to be based on patient census rather than individual users.
More positive than 86% of claims this week
Amesite expects to begin onboarding the first EMR customers in January 2026.
More positive than 63% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company announced a major AI-native EMR product launch following strong sequential revenue growth and enterprise adoption.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Benzinga
3h ago
−54.2%
Price is moving against the score
$1.04 vs $2.27 close before publication (Dec 18) · not market-adjusted
AMST chart →
